Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (439) 439
Publication (79) 79
Book / eBook (13) 13
Conference Proceeding (5) 5
Newspaper Article (4) 4
Dissertation (3) 3
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (230) 230
index medicus (165) 165
female (131) 131
male (129) 129
oncology (120) 120
middle aged (112) 112
aged (97) 97
adult (93) 93
breast cancer (67) 67
cancer (57) 57
prostate cancer (52) 52
breast neoplasms - drug therapy (51) 51
article (49) 49
treatment outcome (47) 47
research (44) 44
chemotherapy (43) 43
tamoxifen (42) 42
aged, 80 and over (39) 39
care and treatment (38) 38
prognosis (37) 37
chemotherapy, adjuvant (35) 35
health aspects (33) 33
therapy (32) 32
analysis (31) 31
antineoplastic agents, hormonal - therapeutic use (30) 30
clinical trials (30) 30
disease-free survival (30) 30
urology & nephrology (30) 30
survival (29) 29
antineoplastic combined chemotherapy protocols - therapeutic use (28) 28
tamoxifen - therapeutic use (28) 28
postmenopausal women (27) 27
prostatic neoplasms - pathology (27) 27
risk factors (27) 27
men (26) 26
animals (25) 25
abridged index medicus (24) 24
expression (24) 24
prospective studies (24) 24
retrospective studies (24) 24
risk (23) 23
time factors (23) 23
prostate-specific antigen - blood (22) 22
follow-up studies (21) 21
neoplasm staging (21) 21
quality of life (21) 21
diet (20) 20
patients (20) 20
women (20) 20
breast neoplasms - genetics (19) 19
breast neoplasms - pathology (19) 19
carcinoma (19) 19
endocrine therapy (19) 19
radical prostatectomy (19) 19
urology (19) 19
double-blind method (18) 18
hematology, oncology and palliative medicine (18) 18
nutrition & dietetics (18) 18
predictive value of tests (18) 18
prostatic neoplasms - blood (18) 18
surgery (18) 18
amino acids (17) 17
antineoplastic agents - therapeutic use (17) 17
genetic aspects (17) 17
oxidation-reduction (17) 17
physiological aspects (17) 17
recurrence (17) 17
tumors (17) 17
biopsy (16) 16
breast neoplasms - mortality (16) 16
breast neoplasms - surgery (16) 16
estrogen (16) 16
nutritional requirements (16) 16
studies (16) 16
survival analysis (16) 16
immunohistochemistry (15) 15
medical research (15) 15
medicine, general & internal (15) 15
prostatic neoplasms - drug therapy (15) 15
randomized controlled trials as topic (15) 15
risk assessment (15) 15
tamoxifen - administration & dosage (15) 15
aromatase inhibitors - therapeutic use (14) 14
cohort studies (14) 14
disease progression (14) 14
genotype (14) 14
kaplan-meier estimate (14) 14
leucine (14) 14
medical colleges (14) 14
medicine & public health (14) 14
metabolism (14) 14
original reports (14) 14
oxidation (14) 14
prostatic neoplasms - genetics (14) 14
proteins (14) 14
surveys and questionnaires (14) 14
trial (14) 14
carcinoma, renal cell - drug therapy (13) 13
drug therapy (13) 13
kidney neoplasms - drug therapy (13) 13
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Gerstein Science - Stacks (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Music - Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Oversize (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Reply to K.-D. Yu et al
by Ruhstaller, Thomas and Regan, Meredith M
Journal of Clinical Oncology, ISSN 0732-183X, 06/2019, Volume 37, Issue 17, pp. 1516 - 1517
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Exemestane with varian suppression in premenopausal Breast Cancer
by Pagani, Olivia and Pagani, Olivia and Regan, Meredith M and Regan, Meredith M and Francis, Prudence A and Francis, Prudence A and TEXT and SOFT Investigators, and SOFT Investigators and International Breast Cancer Study Group, Breast Cancer Study Group
The New England journal of medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1358 - 1359
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
by Montemurro, Filippo and Perrone, Francesco and Geuna, Elena and Francis, Prudence A and Regan, Meredith M and Fleming, Gini F
The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 17, pp. 1672 - 1673
To the Editor: The results of the Suppression of Ovarian Function Trial (SOFT) by Francis et al. (Jan. 29 issue) 1 are presented as practice changing. However,... 
MEDICINE, GENERAL & INTERNAL | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Aromatase Inhibitors - therapeutic use | Breast Neoplasms - drug therapy | Chemotherapy | Breast cancer | Invasiveness | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prevalence of germline variants in inflammatory breast cancer
by Rana, Huma Q and Sacca, Rosalba and Drogan, Christine and Gutierrez, Stephanie and Schlosnagle, Emily and Regan, Meredith M and Speare, Virginia and LaDuca, Holly and Dolinsky, Jill and Garber, Judy E and Overmoyer, Beth A
Cancer, ISSN 0008-543X, 07/2019, Volume 125, Issue 13, pp. 2194 - 2202
Background Inflammatory breast cancer (IBC) is an uncommon and aggressive subtype of breast cancer associated with early disease recurrence and short survival.... 
BRCA | inflammatory breast cancer | mutations | germline | pathogenic | variants | DNA repair | BRCA2 protein | BRCA1 protein | Genes | Estrogens | Breast cancer | Inflammation | Genetic diversity | Carcinogenesis | ErbB-2 protein | Genetic screening | Metastases | Carcinogens | Epidermal growth factor | Testing laboratories | Womens health | Breast | Mutation | Progesterone | Growth factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Reply to Y. Zhu et al
by Xie, Wanling and Regan, Meredith M and Sweeney, Christopher J
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5, pp. 515 - 516
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
by Chlebowski, RT and Pan, K and International Breast Cancer Study Group and TEXT and SOFT Investigators
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1358 - 1358
TRIAL | WOMEN | MEDICINE, GENERAL & INTERNAL | ADJUVANT ENDOCRINE THERAPY | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Redox, amino acid, and fatty acid metabolism intersect with bacterial virulence in the gut
by Reed Pifer and Regan M Russell and Aman Kumar and Meredith M Curtis and Vanessa Sperandio
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2018, Volume 115, Issue 45, p. E10712
The gut metabolic landscape is complex and is influenced by the microbiota, host physiology, and enteric pathogens. Pathogens have to exquisitely monitor the... 
Pathogens | Digestive system | Serine | Virulence | Anaerobic conditions | Variations | Biogeography | Amino acids | Gastrointestinal tract | Infections | Metabolism | Gene expression | Fatty acids | Microbiota | E coli | Pathways | Gastrointestinal system | Metabolic pathways | Digestive tract | Colonization | Citrobacter
Journal Article
Details down arrow
8. Full Text Clinical and economic outcomes associated with sequential treatment in patients with advanced renal cell carcinoma (aRCC)
by Regan, Meredith M and McDermott, David F and Atkins, Michael B and Ambavane, Apoorva and Yang, Shuo and Rao, Sumati and Michaelson, M Dror
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 4566 - 4566
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
by Love, Richard R and Patel, Amol and Gupta, Vineet G and Chlebowski, Rowan T and Pan, Kathy and Francis, Prudence A and Pagani, Olivia and Regan, Meredith M
The New England Journal of Medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 17, pp. 1683 - 1685
To the Editor: The results of the Suppression of Ovarian Function Trial (SOFT) and the Tamoxifen and Exemestane Trial (TEXT) reported by Francis et al. (July... 
MEDICINE, GENERAL & INTERNAL | SURGICAL OOPHORECTOMY | TAMOXIFEN | Low income groups | Aromatase | Pituitary (anterior) | Gonadotropins | Breast cancer | Gonadotropin-releasing hormone | Tamoxifen | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition—A Pooled Analysis of Patients With Advanced Melanoma
by Regan, Meredith M and Werner, Lillian and Rao, Sumati and Gupte-Singh, Komal and Hodi, F. Stephen and Kirkwood, John M and Kluger, Harriet M and Larkin, James and Postow, Michael A and Ritchings, Corey and Sznol, Mario and Tarhini, Ahmad A and Wolchok, Jedd D and Atkins, Michael B and McDermott, David F
Journal of Clinical Oncology, ISSN 0732-183X, 12/2019, Volume 37, Issue 35, pp. 3350 - 3358
PURPOSE Outcome measures that comprehensively capture attributes of immuno-oncology agents, including prolonged treatment-free time and persistent... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows
by Regan, MM and Fleming, GF and Walley, B and Francis, PA and Pagani, O
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 04/2019, Volume 37, Issue 11, pp. 862 - 862
OVARIAN SUPPRESSION | BENEFIT | IMPACT | EFFICACY | ONCOLOGY | ENDOCRINE THERAPY | TEXT | EXPRESSION | CHEMOTHERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The authors reply
by Francis, Prudence A and Regan, Meredith M and Fleming, Gini F
New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 17, p. 1673
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer
by Einstein, David J and Patil, Dattatraya and Chipman, Jonathan and Regan, Meredith M and Davis, Kyle and Crociani, Catrina M and Wagner, Andrew A and Sanda, Martin G and Chang, Peter
Urology, ISSN 0090-4295, 05/2019, Volume 127, pp. 53 - 60
To test the validity of an Internet-based version of Expanded Prostate Cancer Index Composite (EPIC-26) versus the phone-based version. Most men will survive... 
SATISFACTION | PAPER-AND-PENCIL | MEN | VERSION | UROLOGY & NEPHROLOGY | REPORTED OUTCOME MEASURES | RELIABILITY | CARE | Prostatic Neoplasms - pathology | Prospective Studies | Age Factors | Risk Assessment | Sickness Impact Profile | Neoplasm Invasiveness | Telephone - statistics & numerical data | Humans | Middle Aged | Internet - statistics & numerical data | Male | Prostatic Neoplasms - psychology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Survival Analysis | Quality of Life | Aged | Neoplasm Staging | Longitudinal Studies | Cohort Studies | Urinary incontinence | Medical research | Care and treatment | Analysis | Medicine, Experimental | Internet | Prostate cancer | Sexual disorders | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
by Pagani, Olivia and Francis, Prudence A and Fleming, Gini F and Walley, Barbara A and Viale, Giuseppe and Colleoni, Marco and Láng, István and Gómez, Henry L and Tondini, Carlo and Pinotti, Graziella and Di Leo, Angelo and Coates, Alan S and Goldhirsch, Aron and Gelber, Richard D and Regan, Meredith M and for the SOFT and TEXT Investigators and International Breast Cancer Study Group
Journal of Clinical Oncology, ISSN 0732-183X, 10/2019, p. JCO.18.01967
PURPOSE The Tamoxifen and Exemestane Trial (TEXT)/Suppression of Ovarian Function Trial (SOFT) showed superior outcomes for premenopausal women with hormone... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Abstract 4207: Androgen receptor expression and ER+ breast cancer prognosis in the BIG 1-98 trial
by Kensler, Kevin H and Regan, Meredith M and Heng, Yujing J and Pyle, Michael E and Schnitt, Stuart J and Thürlimann, Beat and Viale, Giuseppe and Colleoni, Marco and Brown, Myles and Tamimi, Rulla M
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 4207 - 4207
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
by Amoroso, Vito and Berruti, Alfredo and Simoncini, Edda and Chlebowski, Rowan T and Pan, Kathy and Prasad, Vinay and Pagani, Olivia and Regan, Meredith M and Francis, Prudence A
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1357 - 1359
To the Editor: In a planned subgroup analysis of the Tamoxifen and Exemestane Trial (TEXT) and the Suppression of Ovarian Function Trial (SOFT) reported by... 
WOMEN | MEDICINE, GENERAL & INTERNAL | TAMOXIFEN | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Epidermal growth factor | Aromatase | Breast cancer | Tamoxifen | Health risk assessment | ErbB-2 protein | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Sensitivity of treatment-free survival (TFS), a novel outcome, to subgroup analyses of patients (pts) with advanced melanoma (MEL) treated with immune checkpoint inhibitors (ICI)
by Mantia, Charlene and Werner, Lillian and Rao, Sumati and Ritchings, Corey and Tarhini, Ahmad A and Atkins, Michael B and McDermott, David F and Regan, Meredith M
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 9550 - 9550
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy: A Breast International Group (BIG) 1-98 sub-analyses
by Leone, Jose Pablo and Cole, Bernard F and Regan, Meredith M and Thurlimann, Beat J. K and Coates, Alan S and Goldhirsch, Aron and Di Leo, Angelo and Colleoni, Marco and Luis, Ines Maria Vaz Duarte and Lin, Nancy U
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 538 - 538
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Reply to F. Tomao et al
by Ribi, Karin and Bernhard, Jürg and Luo, Weixiu and Regan, Meredith M and Fleming, Gini F and Francis, Prudence A
Journal of Clinical Oncology, ISSN 0732-183X, 12/2016, Volume 34, Issue 34, pp. 4189 - 4190
Prostatic Neoplasms | Humans | Correspondence
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Treatment-free survival (TFS), a novel outcome applied to immuno-oncology (IO) agents in advanced melanoma (AM)
by Regan, Meredith M and Werner, Lillian and Tarhini, Ahmad A and Rao, Sumati and Gupte-Singh, Komal and Ritchings, Corey and Atkins, Michael B and McDermott, David F
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 9531 - 9531
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.